June 20, 2017 | Israeli medical marijuana startup iCAN has announced a joint venture with Australian company LeafCann Research and Advisory. The new venture will take advantage of Israel’s leadership position in the research and development of medical marijuana, in combination with Australia’s lax regulations. Founded in 2015, iCAN is a leading Israeli developer of cannabis-based formulations, clinical trials and cannabis testing. The firm is headed by Saul Kaye.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments